Actions and Detail Panel
Navigating Regulatory Requirements for Redistributed Manufacturing in Healt...
Fri 14 October 2016, 09:00 – 17:00 BST
This event will review and advance understanding of regulatory requirements affecting distributed models of manufacturing in healthcare. Expert speakers include regulators, academia, industry and professional bodies, incl. MHRA, BSI, EATRIS, UK-CPI and the LGC Group.
Our aim is to present future strategies and pathways for disruptive innovations that bring manufacturing closer to the point of clinical need or use. This event focuses on the regulatory aspects of distributed models of manufacturing.
We invite you to contribute your expertise at this forum to help position the UK at the forefront of healthcare manufacturing. This event is part of a wider research programme, run by a team of multi-disciplinary academic researchers from six UK universities, and is sponsored by the Engineering and Physical Sciences Research Council (www.epsrc.ac.uk).
We want to hear from anyone involved in the re-distribution of manufacturing in healthcare. Whether you are conducting early stage R&D, in the process of clinical trials, commercialising a new technology/process, or reviewing or procuring new solutions that involve bringing manufacturing closer to clinical need or use.
All types of organisations within the United Kingdom are encouraged to attend, particularly clinicians, academia and industry. We are keen to help identify and publicise breakthrough achievements and novel systems / technologies that will significantly impact the future of point-of-care manufacturing.
As a participant in this workshop, you will be invited to openly share your expertise and participate in roadmapping exercises. The outputs will be compiled into our public white paper, which aims to inform future funding and investment in this area. Whilst individual contributions will be made non-identifiable, if you wish to add your team and organisation to the list of participants in the white paper please indicate this to the organising team (firstname.lastname@example.org). If you wish to participate in more detailed interviews or work with us to develop a case study for the white paper report, please also indicate your interest by contacting us by email directly.
By attending this workshop you agree that you have read this participant statement and have given us permission to store and use your written and oral contributions for scholarly purposes. You may withdraw your consent at any time by writing to us (email@example.com) before the end of the RiHN research programme on Jan 31st 2017. Your name, organisation and contact details will only be used to authenticate your attendance and provide statistical data on participant type: these details will be deleted after we have sent out the white paper report to all participants.
We look forward to meeting you.
Dr Wendy Phillips (firstname.lastname@example.org)
Prof Nick Medcalf (email@example.com)